JAMA子刊:吸烟和多基因风险评分对肺功能降低的相互作用

2021-12-28 MedSci原创 MedSci原创

气流受限和慢性阻塞性肺疾病(COPD)的风险受吸烟和遗传易感性组合的影响

气流受限和慢性阻塞性肺疾病(COPD)的风险受吸烟和遗传易感性组合的影响,但目前仍不清楚基因与吸烟的相互作用是否与肺功能的定量测量相关。为了评估吸烟和多基因风险评分与肺功能下降的相互作用,来自美国布里格姆和妇女医院的专家开展了相关研究,结果发表在JAMA Network Open杂志上。

这项英国生物库队列研究包括40至69岁具有欧洲血统的英国公民,其遗传和肺活量数据通过质量控制指标。暴露因素为1秒内用力呼气容积(FEV1)和第一秒内用力呼气容量的百分比(FEV1/FVC)的PRS,自我报告的吸烟包年数,曾经吸烟与从未吸烟的状态,以及目前吸烟与以前或从未吸烟的状态。

该研究中,FEV1/FVC是主要结果。模型用于检验与模型的相互作用,包括多基因风险得分(PRS)的主效应、不同的吸烟变量以及它们的交叉乘积项。对肺功能低下的估计遗传风险的最高和最低十分位数的人,比较吸烟包年和FEV1/FVC之间的关系。

共纳入了319730人,其中24915人(8%)有中度至重度COPD病例,44.4%为男性。参与者的平均(SD)年龄为56.5(8.02)岁。总的来说,PRS和吸烟包-年与FEV1/FVC的降低显著相关(PRS:β=-0.03;95%CI,-0.031至-0.03;吸烟包-年:β=-0.0064;95%CI,-0.0064至-0.0063)和交互项(β=-0.0028;95%CI,-0.0029至-0.0026)。

总的来说,吸烟指数每增加10包烟年,这些交互项的估计效应大小就会逐步递增。PRS与11-20、31-40和50包年以上类别的交互作用分别为-0.0038、-0.013和-0.017。有证据表明,PRS与曾经或从未吸烟的状态(β=-0.0064;95% CI,-0.0068至-0.0060)和目前吸烟(β=-0.0091;95% CI,-0.0097至-0.0084)之间有显著的交互作用。

多基因风险评分与FEV1/FVC之间的关系

对于任何给定的吸烟年数,处于第十个十分位数(即最高风险)的个体的FEV1/FVC明显低于第一个十分位数(即最低风险)的遗传风险。每吸烟20包年,处于第十个十分位数的人与处于第一个十分位数的遗传风险的人相比,FEV1/FVC几乎下降了2倍。

综上,全基因组PRS和吸烟暴露之间存在大量的相互作用。在所有的遗传风险类别中,吸烟与肺功能下降有关,尤其是在估计遗传风险较高的个体中,这种关联最强。

 

参考文献:

Interaction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function. JAMA Netw Open. 2021;4(12):e2139525. doi:10.1001/jamanetworkopen.2021.39525

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1909326, encodeId=3bb71909326cf, content=<a href='/topic/show?id=8039e2512e8' target=_blank style='color:#2F92EE;'>#相互作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72512, encryptionId=8039e2512e8, topicName=相互作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Aug 27 09:07:46 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949778, encodeId=eaeb1949e7805, content=<a href='/topic/show?id=b1ec431e5ab' target=_blank style='color:#2F92EE;'>#多基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43175, encryptionId=b1ec431e5ab, topicName=多基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Sun May 22 09:07:46 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754470, encodeId=6ae71e5447018, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Fri Mar 04 10:07:46 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632091, encodeId=9c47163209175, content=<a href='/topic/show?id=5138431e665' target=_blank style='color:#2F92EE;'>#多基因风险评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43176, encryptionId=5138431e665, topicName=多基因风险评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1a21855288, createdName=lq0308, createdTime=Tue Jul 05 13:07:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085376, encodeId=7d1510853e644, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282986430, createdName=15288412745, createdTime=Wed Dec 29 10:31:11 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704518, encodeId=1fa81e045183a, content=<a href='/topic/show?id=1f5b41931ce' target=_blank style='color:#2F92EE;'>#基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41931, encryptionId=1f5b41931ce, topicName=基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jan 23 09:07:46 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471695, encodeId=9c8714e169535, content=<a href='/topic/show?id=c0132410554' target=_blank style='color:#2F92EE;'>#互作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24105, encryptionId=c0132410554, topicName=互作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc87121468, createdName=ylz8405, createdTime=Tue Dec 21 10:07:46 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1909326, encodeId=3bb71909326cf, content=<a href='/topic/show?id=8039e2512e8' target=_blank style='color:#2F92EE;'>#相互作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72512, encryptionId=8039e2512e8, topicName=相互作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Aug 27 09:07:46 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949778, encodeId=eaeb1949e7805, content=<a href='/topic/show?id=b1ec431e5ab' target=_blank style='color:#2F92EE;'>#多基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43175, encryptionId=b1ec431e5ab, topicName=多基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Sun May 22 09:07:46 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754470, encodeId=6ae71e5447018, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Fri Mar 04 10:07:46 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632091, encodeId=9c47163209175, content=<a href='/topic/show?id=5138431e665' target=_blank style='color:#2F92EE;'>#多基因风险评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43176, encryptionId=5138431e665, topicName=多基因风险评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1a21855288, createdName=lq0308, createdTime=Tue Jul 05 13:07:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085376, encodeId=7d1510853e644, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282986430, createdName=15288412745, createdTime=Wed Dec 29 10:31:11 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704518, encodeId=1fa81e045183a, content=<a href='/topic/show?id=1f5b41931ce' target=_blank style='color:#2F92EE;'>#基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41931, encryptionId=1f5b41931ce, topicName=基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jan 23 09:07:46 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471695, encodeId=9c8714e169535, content=<a href='/topic/show?id=c0132410554' target=_blank style='color:#2F92EE;'>#互作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24105, encryptionId=c0132410554, topicName=互作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc87121468, createdName=ylz8405, createdTime=Tue Dec 21 10:07:46 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1909326, encodeId=3bb71909326cf, content=<a href='/topic/show?id=8039e2512e8' target=_blank style='color:#2F92EE;'>#相互作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72512, encryptionId=8039e2512e8, topicName=相互作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Aug 27 09:07:46 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949778, encodeId=eaeb1949e7805, content=<a href='/topic/show?id=b1ec431e5ab' target=_blank style='color:#2F92EE;'>#多基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43175, encryptionId=b1ec431e5ab, topicName=多基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Sun May 22 09:07:46 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754470, encodeId=6ae71e5447018, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Fri Mar 04 10:07:46 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632091, encodeId=9c47163209175, content=<a href='/topic/show?id=5138431e665' target=_blank style='color:#2F92EE;'>#多基因风险评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43176, encryptionId=5138431e665, topicName=多基因风险评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1a21855288, createdName=lq0308, createdTime=Tue Jul 05 13:07:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085376, encodeId=7d1510853e644, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282986430, createdName=15288412745, createdTime=Wed Dec 29 10:31:11 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704518, encodeId=1fa81e045183a, content=<a href='/topic/show?id=1f5b41931ce' target=_blank style='color:#2F92EE;'>#基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41931, encryptionId=1f5b41931ce, topicName=基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jan 23 09:07:46 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471695, encodeId=9c8714e169535, content=<a href='/topic/show?id=c0132410554' target=_blank style='color:#2F92EE;'>#互作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24105, encryptionId=c0132410554, topicName=互作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc87121468, createdName=ylz8405, createdTime=Tue Dec 21 10:07:46 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-03-04 syscxl
  4. [GetPortalCommentsPageByObjectIdResponse(id=1909326, encodeId=3bb71909326cf, content=<a href='/topic/show?id=8039e2512e8' target=_blank style='color:#2F92EE;'>#相互作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72512, encryptionId=8039e2512e8, topicName=相互作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Aug 27 09:07:46 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949778, encodeId=eaeb1949e7805, content=<a href='/topic/show?id=b1ec431e5ab' target=_blank style='color:#2F92EE;'>#多基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43175, encryptionId=b1ec431e5ab, topicName=多基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Sun May 22 09:07:46 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754470, encodeId=6ae71e5447018, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Fri Mar 04 10:07:46 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632091, encodeId=9c47163209175, content=<a href='/topic/show?id=5138431e665' target=_blank style='color:#2F92EE;'>#多基因风险评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43176, encryptionId=5138431e665, topicName=多基因风险评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1a21855288, createdName=lq0308, createdTime=Tue Jul 05 13:07:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085376, encodeId=7d1510853e644, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282986430, createdName=15288412745, createdTime=Wed Dec 29 10:31:11 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704518, encodeId=1fa81e045183a, content=<a href='/topic/show?id=1f5b41931ce' target=_blank style='color:#2F92EE;'>#基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41931, encryptionId=1f5b41931ce, topicName=基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jan 23 09:07:46 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471695, encodeId=9c8714e169535, content=<a href='/topic/show?id=c0132410554' target=_blank style='color:#2F92EE;'>#互作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24105, encryptionId=c0132410554, topicName=互作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc87121468, createdName=ylz8405, createdTime=Tue Dec 21 10:07:46 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1909326, encodeId=3bb71909326cf, content=<a href='/topic/show?id=8039e2512e8' target=_blank style='color:#2F92EE;'>#相互作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72512, encryptionId=8039e2512e8, topicName=相互作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Aug 27 09:07:46 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949778, encodeId=eaeb1949e7805, content=<a href='/topic/show?id=b1ec431e5ab' target=_blank style='color:#2F92EE;'>#多基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43175, encryptionId=b1ec431e5ab, topicName=多基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Sun May 22 09:07:46 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754470, encodeId=6ae71e5447018, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Fri Mar 04 10:07:46 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632091, encodeId=9c47163209175, content=<a href='/topic/show?id=5138431e665' target=_blank style='color:#2F92EE;'>#多基因风险评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43176, encryptionId=5138431e665, topicName=多基因风险评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1a21855288, createdName=lq0308, createdTime=Tue Jul 05 13:07:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085376, encodeId=7d1510853e644, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282986430, createdName=15288412745, createdTime=Wed Dec 29 10:31:11 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704518, encodeId=1fa81e045183a, content=<a href='/topic/show?id=1f5b41931ce' target=_blank style='color:#2F92EE;'>#基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41931, encryptionId=1f5b41931ce, topicName=基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jan 23 09:07:46 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471695, encodeId=9c8714e169535, content=<a href='/topic/show?id=c0132410554' target=_blank style='color:#2F92EE;'>#互作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24105, encryptionId=c0132410554, topicName=互作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc87121468, createdName=ylz8405, createdTime=Tue Dec 21 10:07:46 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-29 15288412745

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1909326, encodeId=3bb71909326cf, content=<a href='/topic/show?id=8039e2512e8' target=_blank style='color:#2F92EE;'>#相互作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72512, encryptionId=8039e2512e8, topicName=相互作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Aug 27 09:07:46 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949778, encodeId=eaeb1949e7805, content=<a href='/topic/show?id=b1ec431e5ab' target=_blank style='color:#2F92EE;'>#多基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43175, encryptionId=b1ec431e5ab, topicName=多基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Sun May 22 09:07:46 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754470, encodeId=6ae71e5447018, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Fri Mar 04 10:07:46 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632091, encodeId=9c47163209175, content=<a href='/topic/show?id=5138431e665' target=_blank style='color:#2F92EE;'>#多基因风险评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43176, encryptionId=5138431e665, topicName=多基因风险评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1a21855288, createdName=lq0308, createdTime=Tue Jul 05 13:07:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085376, encodeId=7d1510853e644, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282986430, createdName=15288412745, createdTime=Wed Dec 29 10:31:11 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704518, encodeId=1fa81e045183a, content=<a href='/topic/show?id=1f5b41931ce' target=_blank style='color:#2F92EE;'>#基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41931, encryptionId=1f5b41931ce, topicName=基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jan 23 09:07:46 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471695, encodeId=9c8714e169535, content=<a href='/topic/show?id=c0132410554' target=_blank style='color:#2F92EE;'>#互作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24105, encryptionId=c0132410554, topicName=互作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc87121468, createdName=ylz8405, createdTime=Tue Dec 21 10:07:46 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1909326, encodeId=3bb71909326cf, content=<a href='/topic/show?id=8039e2512e8' target=_blank style='color:#2F92EE;'>#相互作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72512, encryptionId=8039e2512e8, topicName=相互作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Aug 27 09:07:46 CST 2022, time=2022-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949778, encodeId=eaeb1949e7805, content=<a href='/topic/show?id=b1ec431e5ab' target=_blank style='color:#2F92EE;'>#多基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43175, encryptionId=b1ec431e5ab, topicName=多基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c49e75, createdName=qjddjq, createdTime=Sun May 22 09:07:46 CST 2022, time=2022-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754470, encodeId=6ae71e5447018, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Fri Mar 04 10:07:46 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632091, encodeId=9c47163209175, content=<a href='/topic/show?id=5138431e665' target=_blank style='color:#2F92EE;'>#多基因风险评分#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43176, encryptionId=5138431e665, topicName=多基因风险评分)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a1a21855288, createdName=lq0308, createdTime=Tue Jul 05 13:07:46 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085376, encodeId=7d1510853e644, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe282986430, createdName=15288412745, createdTime=Wed Dec 29 10:31:11 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704518, encodeId=1fa81e045183a, content=<a href='/topic/show?id=1f5b41931ce' target=_blank style='color:#2F92EE;'>#基因风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41931, encryptionId=1f5b41931ce, topicName=基因风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Sun Jan 23 09:07:46 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1471695, encodeId=9c8714e169535, content=<a href='/topic/show?id=c0132410554' target=_blank style='color:#2F92EE;'>#互作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24105, encryptionId=c0132410554, topicName=互作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc87121468, createdName=ylz8405, createdTime=Tue Dec 21 10:07:46 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-21 ylz8405

相关资讯

JAHA:吸烟与致命和非致命心血管疾病亚型的竞争风险

当前吸烟与作为临床CVD首要表现的致命事件相关。

Tobacco Control:中国必须遏制吸烟,未来二十年,与吸烟相关癌死亡将增加50%

2021年11月1日,中国医学科学院肿瘤医院徐宁志和北京协和医学院姜晶梅等研究人员在 BMJ 子刊" Tobacco Control "期刊发表了一篇题为" Smoking-related cance

Clin Infectious Dis:儿童远离吸烟患者可以降低患结核的风险

烟草消费,尤其是吸烟,正威胁着全球结核病的控制工作。最近的研究表明,在结核病高负担国家,18%的结核病病例和15%的结核病死亡率可归因于吸烟。

重磅!柳叶刀子刊揭示中国香港连续7年成为更长寿地区的关键!

Lancet Public Health:了解香港的长寿:与长寿的高收入国家的比较研究

大部分女性不抽烟,为何还会得肺癌?

最近数据显示,2000~2014年间,我国女性的肺癌发病率从27.77/10万增长到51.31/10万,翻了将近一倍,她们中约80%从不吸烟,从不吸烟女性患肺癌的可能性是从未吸烟男性的两倍。

从不吸烟与既往吸烟的肺癌患者空气污染暴露情况比较

从不吸烟的肺癌患者与女性、亚裔和空气污染暴露密切相关。

拓展阅读

BMC Oral Health:牙周治疗后吸烟者和非吸烟者血清生物标志物水平的变化

本文比较吸烟者和非吸烟者牙周炎患者在牙周治疗后血清细胞因子的存在和水平。

Eur J Prev Cardiol:1990-2019年吸烟导致的全球心血管疾病负担

吸烟导致的心血管疾病发病率和死亡率在全球范围内正在下降,但显著差异仍然存在,表明需要有针对性的干预措施来减少吸烟相关的心血管疾病负担。

AJHG:跨6个不同种族/民族表观基因组关联研究揭示吸烟与DNA甲基化的联系

该研究是迄今为止规模最大的多种族研究之一,突出显示了内部尼古丁摄入量与DNA甲基化的跨种族/民族特异性关联,揭示内部尼古丁摄入量是吸烟相关疾病的强有力预测因子。

Gastric Cancer:吸烟与胃癌风险之间的剂量反应关系

吸烟是胃癌的独立危险因素,尤其是贲门癌。每天吸烟20支以下,患胃癌的风险就会增加,并且随着吸烟时间的延长而呈剂量依赖性增加。

Int. J. Ment. Health Addiction:出院后基于电话的戒烟干预对严重精神健康障碍患者的有效性

这项研究证明了通过现有的区域戒烟热线提供的主动的、基于激励性的电话干预的有效性。该干预措施旨在帮助最近从急性精神病住院治疗中出院的患有精神健康和药物滥用障碍的无动机吸烟者。

World Allergy Organ J:母亲在分娩前后吸烟及其对后代过敏性疾病的影响:一项孟德尔随机化研究

研究人员分析了在调整或不调整母乳喂养影响的情况下,母亲在婴儿出生前后吸烟与后代过敏性疾病之间的关联性情况。强调了分娩前后戒烟的紧迫性以及母乳喂养的重要性。